DNA signs agreement
10 August 2010
This license offers Ion Torrent access to DNA Electronics’ intellectual property.
DNA Electronics Ltd has signed a non-exclusive, worldwide license agreement to provide Ion Torrent, the semiconductor sequencing company, access to DNA’s intellectual property. No further details about the agreement have been disclosed.
DNA Electronics Founder and CEO Prof. Chris Toumazou FRS, an electronic engineer and innovator who has spent his career working in semiconductor technology, moved into healthcare because he saw the benefits chip technology could offer clinicians.
“I’ve always believed that if you could apply just a fraction of semiconductor technology to healthcare, you can begin to make major innovations,” said Toumazou. “Those innovations are now very near on the horizon, and the great work that DNA Electronics has been doing positions our company to play a key role in this coming healthcare revolution. I am delighted that Ion Torrent is pioneering semiconductor sequencing, and I believe this will bring about a new semiconductor revolution in the Life Sciences and Healthcare industries.”
DNA Electronics is a provider of scalable semiconductor solutions for real-time nucleic acid detection which enable faster, simpler and more cost-effective DNA analysis platforms. The company’s IP portfolio includes techniques for monitoring nucleotide insertions using solid-state biosensors on standard CMOS chip technology, enabling label-free electronic DNA sequencing and diagnostics platforms. DNA Electronics (DNAe) has developed the Genalysis platform of disposable silicon chip-based solutions for real-time nucleic acid sequence detection at the point of care, providing end users with technology as yet unavailable outside a laboratory.
Contact Details and Archive...
Related Articles...
Most Viewed Articles...